← Leaderboards
Welkin E Johnson
Harvard University (Medical School)
$15,505,977
Attributed
$15,505,977
Total exposure
21
Grants
21
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.5M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,505,977 · 21
By mechanism
R01$11,423,917 · 4
P51$2,407,267 · 13
R21$892,293 · 2
R56$782,500 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Acquired Immunodeficiency Syndrome”
- David Heimbrook · Leidos Biomedical Research, Inc.$300,790,583
- George R Seage · Abt Associates, Inc.$244,444,207
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$180,045,219
- Barbara Driver · Westat, Inc.$168,632,670
- Michelle Vargas · Ppd Development Lp$163,846,102
- Judith S. Currier · University Of California Los Angeles$150,146,659
Research focus
Acquired Immunodeficiency SyndromeHiv-1InfectionPrimatesMacacaMacaca MulattaBaseViralResistanceMediatingPathogenesisBiologicalProteinsIn VivoAnimalsVirus DiseasesGenesHiv-2CellsSpecificityVariantVirusCell LineNonhuman Primate
Grant awards (43)
Replication and Evolution of Primate Lentiviruses.$2,505,639
R01 · FY2025 · AI · contact PI
Replication and Evolution of Primate Lentiviruses$348,750
R56 · FY2024 · AI · contact PI
Cross-species transmission and adaptation of primate lentiviruses$391,250
R01 · FY2019 · AI · contact PI
Simple Retroviruses and Resistance to Tetherin$195,625
R21 · FY2019 · AI · contact PI
Cross-species transmission and adaptation of primate lentiviruses$391,250
R01 · FY2018 · AI · contact PI
Simple Retroviruses and Resistance to Tetherin$195,625
R21 · FY2018 · AI · contact PI
Cross-species transmission and adaptation of primate lentiviruses$391,250
R01 · FY2017 · AI · contact PI
Cross-species transmission and adaptation of primate lentiviruses$391,250
R01 · FY2016 · AI · contact PI
Intrinsic Immunity and AIDS$484,892
R01 · FY2015 · AI · contact PI
Cross-species transmission and adaptation of primate lentiviruses$382,775
R01 · FY2015 · AI · contact PI
Intrinsic Immunity and AIDS$670,613
R01 · FY2014 · AI · contact PI
Intrinsic Immunity and AIDS$526,341
R01 · FY2013 · AI · contact PI
Cross-Species transmission and adaptation of primate lentiviruses$360,457
R01 · FY2013 · AI · contact PI
Intrinsic Immunity and AIDS$559,937
R01 · FY2012 · AI · contact PI
Cross-Species transmission and adaptation of primate lentiviruses$383,464
R01 · FY2012 · AI · contact PI
Intrinsic Immunity and AIDS$579,981
R01 · FY2011 · AI · contact PI
Cross-Species transmission and adaptation of primate lentiviruses$377,857
R01 · FY2011 · AI · contact PI
STRATEGIES OF IMMUNE EVASION IN AIDS$210,597
P51 · FY2011 · RR · contact PI
EDUCATION AND TRAINING$210,597
P51 · FY2011 · RR · contact PI
POLYMORPHISM IN MACAQUE ANTI-RETROVIRAL FACTOR TRIM5ALPHA$204,609
P51 · FY2011 · RR · contact PI
Intrinsic Immunity and AIDS$173,092
R01 · FY2011 · AI · contact PI
Cross-Species transmission and adaptation of primate lentiviruses$47,263
R01 · FY2011 · AI · contact PI
Cross-Species transmission and adaptation of primate lentiviruses$429,413
R01 · FY2010 · AI · contact PI
EDUCATION AND TRAINING$241,117
P51 · FY2010 · RR · contact PI
POLYMORPHISM IN MACAQUE ANTI-RETROVIRAL FACTOR TRIM5ALPHA$202,435
P51 · FY2010 · RR · contact PI
STRATEGIES OF IMMUNE EVASION IN AIDS$202,435
P51 · FY2010 · RR · contact PI
Host Factor Genetics and Susceptibility to Retroviral Infection$433,750
R56 · FY2009 · AI · contact PI
Cross-Species transmission and adaptation of primate lentiviruses$433,750
R01 · FY2009 · AI · contact PI
Replication and Persistence of Primate Lentiviruses$425,509
R01 · FY2009 · AI · contact PI
EDUCATION AND TRAINING$237,884
P51 · FY2009 · RR · contact PI
STRATEGIES OF IMMUNE EVASION IN AIDS$206,081
P51 · FY2009 · RR · contact PI
POLYMORPHISM IN RHESUS MACAQUE ANTI-RETROVIRAL FACTOR TRIM5ALPHA$206,081
P51 · FY2009 · RR · contact PI
Replication and Persistence of Primate Lentiviruses$425,509
R01 · FY2008 · AI · contact PI
POLYMORPHISM IN RHESUS MACAQUE ANTI-RETROVIRAL FACTOR TRIM5ALPHA$135,175
P51 · FY2008 · RR · contact PI
STRATEGIES OF IMMUNE EVASION IN AIDS$135,175
P51 · FY2008 · RR · contact PI
Replication and Persistence of Primate Lentiviruses$419,050
R01 · FY2007 · AI · contact PI
POLYMORPHISM IN RHESUS MACAQUE ANTI-RETROVIRAL FACTOR TRIM5ALPHA$107,541
P51 · FY2007 · RR · contact PI
STRATEGIES OF IMMUNE EVASION IN AIDS$107,540
P51 · FY2007 · RR · contact PI
Transgenic mouse for modifying antiviral mAb specificity$247,543
R21 · FY2006 · AI · contact PI
Transgenic mouse for modifying antiviral mAb specificity$253,500
R21 · FY2005 · AI
Contributions of Antibody to Control of SIV infection$211,250
R01 · FY2005 · AI
Contributions of Antibody to Control of SIV infection$295,750
R01 · FY2004 · AI
Contributions of Antibody to Control of SIV infection$166,375
R01 · FY2003 · AI